# Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas

> **NCT00837031** · PHASE2 · COMPLETED · sponsor: **SCRI Development Innovations, LLC** · enrollment: 72 (actual)

## Conditions studied

- Metastatic Pancreatic Cancer

## Interventions

- **DRUG:** Lenalidomide
- **DRUG:** Gemcitabine

## Key facts

- **NCT ID:** NCT00837031
- **Lead sponsor:** SCRI Development Innovations, LLC
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-02
- **Primary completion:** 2010-04
- **Final completion:** 2012-06
- **Target enrollment:** 72 (ACTUAL)
- **Last updated:** 2013-03-13

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00837031

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00837031, "Lenalidomide With Gemcitabine in Treatment of Untreated Advanced Carcinoma of the Pancreas". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00837031. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*